LLY vs UNH: Which Is the Better Buy?
Side-by-side comparison of Eli Lilly and Company and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Eli Lilly and Company · Healthcare
$1,183.72
+2.1% upside to fair value
Med Conviction
Grade B
High Quality
VS
UnitedHealth Group Incorporated · Healthcare
$375.21
+28.2% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+28.2%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
LLY |
UNH |
| Current Price |
$1,183.72 |
$375.21 |
| Fair Value Estimate |
$1,208.00 |
$481.06 |
| Upside to Fair Value |
+2.1%
|
+28.2%
|
| Market Cap |
$1,114.8B |
$340.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
26.8x
|
15.0x
|
| Price / Sales |
14.0x
|
0.8x
|
| Price / FCF |
52.7x
|
14.4x
|
| Revenue Growth YoY |
+47.7%
|
+0.4%
|
| Gross Margin |
83.4%
|
22.5%
|
| Operating Margin |
49.7%
|
4.8%
|
| Return on Equity |
92.6%
|
14.6%
|
| Dividend Yield |
0.57% |
2.41% |
| FCF Yield |
1.9%
|
6.95%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Eli Lilly is a global pharmaceutical company whose incretin franchise, led by Mounjaro and Zepbound, has become the dominant growth engine in diabetes and obesity care. The business quality is high: TTM gross margin is 83.4%, TTM operating margin is 49.7%, TTM net margin is 33.5%, and ROE is 92.6%, while revenue grew 47.7% and earnings grew 25.3% in the most recent quarter on a year-over-year bas…
UnitedHealth Group is the largest diversified healthcare enterprise in the United States, operating UnitedHealthcare insurance plans alongside Optum Health, Optum Insight, and Optum Rx, with 390,000 employees and a market capitalization of $340.74 billion. The business quality is high: a 14.6% return on equity, $26.07 in free cash flow per share, and a P/FCF of 14.39 demonstrate strong cash gener…
Accumulation Zones
| Metric |
LLY |
UNH |
| Zone Low |
$906.00 |
$360.80 |
| Zone High |
$1,026.80 |
$408.90 |
| In Buy Zone? |
No
|
Yes
|